Stocktoria

Autolus Therapeutics plc AUTL

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-22 · LEI

Autolus Therapeutics plc institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.4,436,102$15.4M1.67%
RENAISSANCE TECHNOLOGIES LLC1,984,700$3.2M0.75%
MILLENNIUM MANAGEMENT LLC1,224,818$2.0M0.46%
CITADEL ADVISORS LLC805,790$1.3M0.3%
Point72 Asset Management, L.P.71,227$113,9630.03%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.